Wikipedia -WSS

Wikipedia

author：explore 2025-10-02 22:15:40 - browse：29397

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution.

“What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that “the impact on health care costs would be very marginal.”

The problem, executives say, is that companies developing cancer drugs today generally start small and then go big. They seek approval first in a small setting, such as patients who have exhausted all other therapies, where it’s easiest in terms of trial size and length to show a benefit. Then they go into larger settings, such as newly diagnosed patients, where studies take longer but the revenue potential is much higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： CDC advisory group OKs chikungunya vaccine

hotspot

WSS

Custom gene therapy hints at new path for rare disease treatments

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Sanders adds drug shortage policies to pandemic preparedness bill

Google and Epic fight stronger regulation of AI in health care

5 ways to address the shortage of health care workers

At Orexo, a ‘turning point’ for everything but digital health

entertainment

Wikipedia

focus

Walensky prepares to leave CDC — and Congress — behind

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

At least 13 dead in Texas as scorching temps continue

Medicare Advantage isn’t working — for anyone

Virginia high school admissions case could be legal follow

Medicare to cover more brain scans for Alzheimer’s patients

Guidelines to prevent youth baseball injuries need more muscle

Color Health wants to make cancer screenings convenient

Psychedelics group wrestles with new pharma identity

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

knowledge

WHO calls for emergency meeting on new China virus, as cases spread

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Custom gene therapy hints at new path for rare disease treatments

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

How Medicaid coverage policies for immigrants impact new moms

entertainment

hotspot

focus

entertainment